SCHEMBL29593200

SCHEMBL29593200

COC(=O)c1nn(C2CCCCO2)c2ccc(Br)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 8/20 0.51
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
MAPK8 P45983 1/20 0.38
ATR Q13535 1/20 0.37
CNR2 P34972 1/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.36
CDK1 P06493 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502931 1.00 ELANE (0.51) ELANERXRARXRBRXRGMAPK8
SCHEMBL16125889 0.88 ELANE (0.41) ELANERXRARXRBRXRGATR
SCHEMBL31005998 0.88 RXRA (0.39) ELANERXRARXRBRXRGATR
SCHEMBL18823955 0.88 HTR3A (0.40) ELANERXRARXRBRXRGATR
SCHEMBL14792743 0.87 RXRA (0.39) ELANERXRARXRBRXRGATR
SCHEMBL16881036 0.87 CNR2 (0.39) ELANERXRARXRBRXRGATR
SCHEMBL6507201 0.86 RXRA (0.41) ELANERXRARXRBRXRGMAPK8
SCHEMBL29121783 0.85 ELANE (0.56) ELANEMAPK8HTTTP53POLB
SCHEMBL31006023 0.84 ELANE (0.53) ELANERXRARXRBRXRGCNR2
SCHEMBL31078730 0.84 ATR (0.37) ELANERXRARXRBRXRGATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120419-A KLK5 bicyclic heteroaromatic inhibitors 拜奥克里斯特制药公司 2023-11-24 CN disclosed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed